+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antihistamine Drugs Market - Global Forecast 2026-2032- Product Image
Antihistamine Drugs Market - Global Forecast 2026-2032- Product Image
New

Antihistamine Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015086
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antihistamine drugs market is rapidly evolving, with decision-makers facing new complexities in clinical innovation, regulatory compliance, and supply chain adaptability. Understanding these trends is essential for optimizing procurement, portfolio management, and strategic planning in a competitive landscape.

Market Snapshot: Antihistamine Drugs Market Growth and Dynamics

The Antihistamine Drugs Market grew from USD 1.95 billion in 2025 to USD 2.11 billion in 2026. It is projected to continue expanding at a CAGR of 8.75%, reaching USD 3.52 billion by 2032. This sustained momentum highlights the sector’s resilience and the increasing demand across global health systems for both established agents and innovative delivery formats.

Scope & Segmentation

  • Therapeutic Generations: First generation antihistamines, recognized for their sedative and anticholinergic effects; second generation antihistamines, which offer improved safety and peripheral selectivity.
  • Delivery Routes: Oral, dermal, nasal, ocular, and parenteral options, each catering to different patient populations and clinical indications.
  • Dosage Formats: Liquid (solutions, syrups), semi-solid (ointments), and solid (capsules, tablets) formulations tailored for pediatric, geriatric, and general systemic use.
  • Distribution Pathways: Hospital pharmacies (public and private), retail pharmacies (chains and independents), and online pharmacies, each impacting price, access, and patient support models.
  • Clinical Applications: Treatment of allergic rhinitis, urticaria, atopic dermatitis, conjunctivitis, and other systemic or localized allergic conditions.
  • Regions Covered: Americas, Europe Middle East & Africa, and Asia-Pacific, each with distinct regulatory, reimbursement, and distribution characteristics.
  • Technology Trends: Innovations in formulation, controlled-release, telemedicine integration, and supply chain digitization are reshaping therapeutic and commercial strategies.

Key Takeaways for Senior Decision-Makers

  • Formulation innovation is shifting the focus toward agents with improved tolerability and adherence, particularly for complex allergy profiles and polypharmacy scenarios.
  • Procurement resilience and supply chain flexibility are now critical, as recent tariff disruptions have prompted firms to invest in regional manufacturing and dual-sourcing strategies.
  • Digital transformation in telehealth, e-prescribing, and remote patient support is changing how antihistamines are accessed, monitored, and evaluated in real time.
  • Strategic product positioning hinges on matching pharmacological profiles with local regulatory requirements, payer dynamics, and hospital or retail channel capabilities.
  • Partnerships between multinational firms, specialty companies, and agile generics are enabling faster market entry, scale, and tailored commercial models in response to evolving global demand.

Tariff Impact: Navigating 2025-Driven Supply Chain Challenges

The 2025 tariff landscape in the United States created significant sourcing and procurement challenges for antihistamine manufacturers, leading to elevated input costs and a reassessment of global supply chain strategies. Companies responded by qualifying secondary suppliers and boosting regional production capacity, which required capital investments and close quality oversight. Downstream, pharmacies prioritized more flexible procurement contracts and performance guarantees to manage volatility, while manufacturers adopted creative pricing and patient support programs to maintain access despite cost pressures.

Methodology & Data Sources

This analysis utilizes primary clinical literature, regulatory documents, pharmacovigilance data, and stakeholder interviews with industry professionals. Cross-validation and triangulation ensure accuracy, while operational and commercial insights are derived from both published sources and real-world procurement practices.

Why This Report Matters

  • Delivers actionable insights for refining product development and aligning commercial strategies with current regulatory and technological trends.
  • Enables procurement and formulary teams to assess supply chain vulnerabilities and adapt sourcing in response to policy or market disruptions.
  • Supports decision-making by presenting region-specific approaches that balance clinical, financial, and regulatory considerations in antihistamine portfolio management.

Conclusion

Senior leaders can strengthen competitiveness and patient access in the antihistamine market by integrating clinical innovation, robust supply chain planning, and digital engagement. Strategic adaptation to these evolving dynamics will determine long-term performance and value delivery in this essential therapeutic area.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Antihistamine Drugs Market, by Drug Type
8.1. H1 Antihistamines
8.1.1. First Generation Antihistamines
8.1.1.1. Chlorpheniramine
8.1.1.2. Diphenhydramine
8.1.1.3. Hydroxyzine
8.1.2. Second Generation Antihistamines
8.1.2.1. Cetirizine
8.1.2.2. Desloratadine
8.1.2.3. Fexofenadine
8.1.2.4. Loratadine
8.2. H2 Antihistamines
8.2.1. Cimetidine
8.2.2. Famotidine
8.2.3. Nizatidine
8.2.4. Ranitidine
8.3. H3 Antihistamines
9. Antihistamine Drugs Market, by Administration Route
9.1. Nasal
9.1.1. Nasal sprays
9.1.2. Nebulizers
9.2. Oral
9.2.1. Capsules
9.2.2. Syrups & Liquids
9.2.3. Tablets
9.3. Parenteral
9.3.1. Intramuscular (IM)
9.3.2. Intravenous (IV)
9.4. Topical
10. Antihistamine Drugs Market, by Dosage Form
10.1. Liquid
10.2. Semi Solid
10.3. Solid
11. Antihistamine Drugs Market, by Indication
11.1. Allergic Conjunctivitis
11.2. Allergic Rhinitis
11.2.1. Perennial Allergic Rhinitis
11.2.2. Seasonal Allergic Rhinitis
11.3. Anaphylaxis Adjunctive Therapy
11.4. Cough & Cold
11.5. Gastroesophageal Reflux Disease And Peptic Ulcer
11.6. Insomnia
11.7. Motion Sickness & Vertigo
11.8. Nausea & Vomiting
11.9. Pruritus & Dermatoses
11.9.1. Atopic Dermatitis Pruritus
11.9.2. Contact Dermatitis Pruritus
11.10. Urticaria
11.10.1. Acute Urticaria
11.10.2. Chronic Spontaneous Urticaria
12. Antihistamine Drugs Market, by Prescription Status
12.1. Over-The-Counter
12.2. Prescription-Only
13. Antihistamine Drugs Market, by Application
13.1. Acute Symptomatic Relief
13.2. Chronic Allergy Management
13.3. Preventive / Prophylactic Use
14. Antihistamine Drugs Market, by Patient Group
14.1. Adult
14.2. Geriatric
14.3. Pediatric
15. Antihistamine Drugs Market, by Sales Channel
15.1. Offline
15.2. Online
16. Antihistamine Drugs Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Antihistamine Drugs Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Antihistamine Drugs Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Antihistamine Drugs Market
20. China Antihistamine Drugs Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Abbott Laboratories
21.6. Alcon Vision LLC
21.7. Almirall, S.A.
21.8. AstraZeneca PLC
21.9. Aurobindo Pharma Limited
21.10. Bayer AG
21.11. Boehringer Ingelheim International GmbH
21.12. Cipla Limited
21.13. Dr.Reddy’s Laboratories Ltd.
21.14. GlaxoSmithKline plc
21.15. GLENMARK PHARMACEUTICALS LTD
21.16. Hikma Pharmaceuticals PLC
21.17. Kenvue Inc.
21.18. Lunan Pharmaceutical Group Corporation
21.19. Lupin Limited
21.20. Merck & Co., Inc.
21.21. Novartis AG
21.22. Perrigo Company plc
21.23. Pfizer Inc.
21.24. Sandoz Group AG
21.25. Sanofi S.A.
21.26. Shanghai Pharmaceuticals Holding Co., Ltd.
21.27. Sun Pharmaceutical Industries Limited
21.28. Teva Pharmaceutical Industries Ltd.
21.29. Torrent Pharmaceuticals Limited
21.30. UCB S.A.
21.31. Viatris Inc.
21.32. Yangtze River Pharmaceutical Group
21.33. Zenomed Healthcare Private Limited
21.34. Zydus Group.
List of Figures
FIGURE 1. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHLORPHENIRAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHLORPHENIRAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHLORPHENIRAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HYDROXYZINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HYDROXYZINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HYDROXYZINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CETIRIZINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CETIRIZINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CETIRIZINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DESLORATADINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DESLORATADINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DESLORATADINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FEXOFENADINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FEXOFENADINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FEXOFENADINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LORATADINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LORATADINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LORATADINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CIMETIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CIMETIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FAMOTIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FAMOTIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NIZATIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NIZATIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RANITIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RANITIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RANITIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H3 ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H3 ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H3 ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL SPRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL SPRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS & LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS & LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS & LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAMUSCULAR (IM), BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAMUSCULAR (IM), BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAMUSCULAR (IM), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAVENOUS (IV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INTRAVENOUS (IV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ANAPHYLAXIS ADJUNCTIVE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ANAPHYLAXIS ADJUNCTIVE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ANAPHYLAXIS ADJUNCTIVE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUGH & COLD, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUGH & COLD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUGH & COLD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INSOMNIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INSOMNIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY MOTION SICKNESS & VERTIGO, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY MOTION SICKNESS & VERTIGO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY MOTION SICKNESS & VERTIGO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NAUSEA & VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NAUSEA & VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NAUSEA & VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ATOPIC DERMATITIS PRURITUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ATOPIC DERMATITIS PRURITUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ATOPIC DERMATITIS PRURITUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CONTACT DERMATITIS PRURITUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CONTACT DERMATITIS PRURITUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CONTACT DERMATITIS PRURITUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE URTICARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE URTICARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE URTICARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC SPONTANEOUS URTICARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC SPONTANEOUS URTICARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC SPONTANEOUS URTICARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION-ONLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION-ONLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION-ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE SYMPTOMATIC RELIEF, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE SYMPTOMATIC RELIEF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACUTE SYMPTOMATIC RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC ALLERGY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC ALLERGY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC ALLERGY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PREVENTIVE / PROPHYLACTIC USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PREVENTIVE / PROPHYLACTIC USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PREVENTIVE / PROPHYLACTIC USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 267. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 268. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 269. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 270. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 271. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 272. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 273. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 274. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 275. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 276. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 277. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 278. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 279. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 280. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 281. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 282. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 283. EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 299. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 300. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 301. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 302. MIDDLE EAST ANTIHISTAMINE DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 303. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 305. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H1 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 306. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 307. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 308. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2 ANTIHISTAMINES, 2018-2032 (USD MILLION)
TABLE 309. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 310. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 311. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 312. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 313. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 314. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 315. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2032 (USD MILLION)
TABLE 316. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY PRURITUS & DERMATOSES, 2018-2032 (USD MILLION)
TABLE 317. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, 2018-2032 (USD MILLION)
TABLE 318. AFRICA ANTIHISTAMINE DRUGS MARKET SIZE

Companies Mentioned

  • Abbott Laboratories
  • Alcon Vision LLC
  • Almirall, S.A.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • Dr.Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • GLENMARK PHARMACEUTICALS LTD
  • Hikma Pharmaceuticals PLC
  • Kenvue Inc.
  • Lunan Pharmaceutical Group Corporation
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sandoz Group AG
  • Sanofi S.A.
  • Shanghai Pharmaceuticals Holding Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Limited
  • UCB S.A.
  • Viatris Inc.
  • Yangtze River Pharmaceutical Group
  • Zenomed Healthcare Private Limited
  • Zydus Group.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.11 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.52 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Antihistamine Market - Global Strategic Business Report - Product Image

Antihistamine Market - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Antihistamine Spray Market - Global Forecast 2025-2030 - Product Image

Antihistamine Spray Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Antihistamine Nose Spray Market - Global Forecast 2025-2030 - Product Image

Antihistamine Nose Spray Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.